{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T01:48:17Z","timestamp":1782352097916,"version":"3.54.5"},"reference-count":48,"publisher":"Elsevier BV","issue":"29","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:00:00Z","timestamp":1685404800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.vaccine.2023.05.068","type":"journal-article","created":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T15:53:57Z","timestamp":1686239637000},"page":"4302-4312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Inactivated influenza virions are a flexible vaccine platform for eliciting protective antibody responses against neuraminidase"],"prefix":"10.1016","volume":"41","author":[{"given":"Mira Rakic","family":"Martinez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongquan","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeog","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Klenow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5\u20136","key":"10.1016\/j.vaccine.2023.05.068_b0005","first-page":"725","article-title":"Vaccination against influenza","volume":"8","author":"Francis","year":"1953","journal-title":"Bull World Health Organ"},{"issue":"5","key":"10.1016\/j.vaccine.2023.05.068_b0010","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/irv.12383","article-title":"An overview of the regulation of influenza vaccines in the United States","volume":"10","author":"Weir","year":"2016","journal-title":"Influenza Other Respir Viruses"},{"issue":"5","key":"10.1016\/j.vaccine.2023.05.068_b0015","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/infdis\/138.5.577","article-title":"Reactogenicity and immunogenicity of whole and ether-Tween-split influenza A virus vaccines in volunteers","volume":"138","author":"Jennings","year":"1978","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2023.05.068_b0020","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1080\/21645515.2015.1016666","article-title":"Cell culture-based influenza vaccines: A necessary and indispensable investment for the future","volume":"11","author":"Hegde","year":"2015","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"10.1016\/j.vaccine.2023.05.068_b0025","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1750-2659.2006.00007.x","article-title":"Production of a novel influenza vaccine using insect cells: protection against drifted strains","volume":"1","author":"Cox","year":"2007","journal-title":"Influenza Other Respir Viruses"},{"issue":"4","key":"10.1016\/j.vaccine.2023.05.068_b0030","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0889-8561(03)00098-5","article-title":"Safety and efficacy of live attenuated, cold-adapted, influenza vaccine-trivalent","volume":"23","author":"Belshe","year":"2003","journal-title":"Immunol Allergy Clin North Am"},{"issue":"1","key":"10.1016\/j.vaccine.2023.05.068_b0035","first-page":"E28","article-title":"Quadrivalent influenza vaccine: A new opportunity to reduce the influenza burden","volume":"57","author":"Tisa","year":"2016","journal-title":"J Prev Med Hyg"},{"key":"10.1016\/j.vaccine.2023.05.068_b0040","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.01914","article-title":"Integrating influenza antigenic dynamics with molecular evolution","volume":"3","author":"Bedford","year":"2014","journal-title":"Elife"},{"issue":"47","key":"10.1016\/j.vaccine.2023.05.068_b0045","doi-asserted-by":"crossref","first-page":"12578","DOI":"10.1073\/pnas.1712377114","article-title":"Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains","volume":"114","author":"Zost","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.vaccine.2023.05.068_b0050","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/0042-6822(88)90640-X","article-title":"Protection against lethal influenza with neuraminidase","volume":"164","author":"Webster","year":"1988","journal-title":"Virology"},{"issue":"25","key":"10.1016\/j.vaccine.2023.05.068_b0055","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJM197206222862502","article-title":"Association of serum anti-neuraminidase antibody with resistance to influenza in man","volume":"286","author":"Murphy","year":"1972","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.vaccine.2023.05.068_b0060","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/infdis\/129.4.411","article-title":"Induction of partial immunity to influenza by a neuraminidase-specific vaccine","volume":"129","author":"Couch","year":"1974","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2023.05.068_b0065","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01959-21","article-title":"Contribution of neuraminidase to the efficacy of seasonal split influenza vaccines in the ferret model","volume":"96","author":"Rosu","year":"2022","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2023.05.068_b0070","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/s41564-019-0401-1","article-title":"Antigenic drift originating from changes to the lateral surface of the neuraminidase head of influenza A virus","volume":"4","author":"Yasuhara","year":"2019","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.vaccine.2023.05.068_b0075","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.3389\/fimmu.2018.01581","article-title":"Influenza a virus cell entry, replication, virion assembly and movement","volume":"9","author":"Dou","year":"2018","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2023.05.068_b0080","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/infdis\/jis935","article-title":"Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase","volume":"207","author":"Couch","year":"2013","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2023.05.068_b0085","doi-asserted-by":"crossref","first-page":"e00417","DOI":"10.1128\/mBio.00417-16","article-title":"Evaluation of antihemagglutinin and antineuraminidase antibodies as correlates of protection in an influenza A\/H1N1 virus healthy human challenge model","volume":"7","author":"Memoli","year":"2016","journal-title":"mBio"},{"issue":"11","key":"10.1016\/j.vaccine.2023.05.068_b0090","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1093\/cid\/ciz639","article-title":"Pre-existing antineuraminidase antibodies are associated with shortened duration of influenza A(H1N1)pdm virus shedding and illness in naturally infected adults","volume":"70","author":"Maier","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2023.05.068_b0095","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/cid\/cix930","article-title":"Benefit of early initiation of neuraminidase inhibitor treatment to hospitalized patients with avian influenza A(H7N9) Virus","volume":"66","author":"Zheng","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"9218","key":"10.1016\/j.vaccine.2023.05.068_b0100","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/S0140-6736(00)02288-1","article-title":"Efficacy and safety of oseltamivir in treatment of acute influenza: A randomised controlled trial. Neuraminidase inhibitor flu treatment investigator group","volume":"355","author":"Nicholson","year":"2000","journal-title":"Lancet"},{"issue":"51","key":"10.1016\/j.vaccine.2023.05.068_b0105","doi-asserted-by":"crossref","first-page":"20748","DOI":"10.1073\/pnas.1113801108","article-title":"Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza viruses","volume":"108","author":"Sandbulte","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.vaccine.2023.05.068_b0110","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00307-19","article-title":"Antigenic drift of the influenza A(H1N1)pdm09 virus neuraminidase results in reduced effectiveness of A\/California\/7\/2009 (H1N1pdm09)-specific antibodies","volume":"10","author":"Gao","year":"2019","journal-title":"MBio"},{"issue":"1","key":"10.1016\/j.vaccine.2023.05.068_b0115","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-022-00500-1","article-title":"Antigenic comparison of the neuraminidases from recent influenza A vaccine viruses and 2019\u20132020 circulating strains","volume":"7","author":"Gao","year":"2022","journal-title":"NPJ Vaccines"},{"issue":"2","key":"10.1016\/j.vaccine.2023.05.068_b0120","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cell.2018.03.030","article-title":"Influenza infection in humans induces broadly cross-reactive and protective neuraminidase-reactive antibodies","volume":"173","author":"Chen","year":"2018","journal-title":"Cell"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2023.05.068_b0125","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0264-410X(97)00279-X","article-title":"Supplementation of conventional influenza A vaccine with purified viral neuraminidase results in a balanced and broadened immune response","volume":"16","author":"Johansson","year":"1998","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2023.05.068_b0130","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02556-14","article-title":"Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice","volume":"6","author":"Wohlbold","year":"2015","journal-title":"MBio"},{"issue":"24","key":"10.1016\/j.vaccine.2023.05.068_b0135","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01160-21","article-title":"Design of the recombinant influenza neuraminidase antigen is crucial for its biochemical properties and protective efficacy","volume":"95","author":"Gao","year":"2021","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2023.05.068_b0140","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02241-21","article-title":"A novel recombinant influenza virus neuraminidase vaccine candidate stabilized by a measles virus phosphoprotein tetramerization domain provides robust protection from virus challenge in the mouse model","volume":"12","author":"Strohmeier","year":"2021","journal-title":"MBio"},{"issue":"1","key":"10.1016\/j.vaccine.2023.05.068_b0145","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-29416-z","article-title":"Structure-based design of stabilized recombinant influenza neuraminidase tetramers","volume":"13","author":"Ellis","year":"2022","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.vaccine.2023.05.068_b0150","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-022-00435-7","article-title":"Pre-existing antibodies directed against a tetramerizing domain enhance the immune response against artificially stabilized soluble tetrameric influenza neuraminidase","volume":"7","author":"Catani","year":"2022","journal-title":"NPJ Vaccines"},{"issue":"8","key":"10.1016\/j.vaccine.2023.05.068_b0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010755","article-title":"Universal protection against influenza viruses by multi-subtype neuraminidase and M2 ectodomain virus-like particle","volume":"18","author":"Kim","year":"2022","journal-title":"PLoS Pathog"},{"issue":"17","key":"10.1016\/j.vaccine.2023.05.068_b0160","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00759-21","article-title":"Universal Influenza Virus Neuraminidase Vaccine Elicits Protective Immune Responses against Human Seasonal and Pre-pandemic Strains","volume":"95","author":"Skarlupka","year":"2021","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2023.05.068_b0165","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-021-00310-x","article-title":"The effect of calcium and magnesium on activity, immunogenicity, and efficacy of a recombinant N1\/N2 neuraminidase vaccine","volume":"6","author":"Giurgea","year":"2021","journal-title":"NPJ Vaccines"},{"issue":"7","key":"10.1016\/j.vaccine.2023.05.068_b0170","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.ymthe.2020.04.018","article-title":"A multi-targeting, nucleoside-modified mRNA influenza virus vaccine provides broad protection in mice","volume":"28","author":"Freyn","year":"2020","journal-title":"Mol Ther"},{"issue":"1","key":"10.1016\/j.vaccine.2023.05.068_b0175","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-32149-8","article-title":"Development of a pentavalent broadly protective nucleoside-modified mRNA vaccine against influenza B viruses","volume":"13","author":"Pardi","year":"2022","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.vaccine.2023.05.068_b0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0233001","article-title":"Low response in eliciting neuraminidase inhibition activity of sera among recipients of a split, monovalent pandemic influenza vaccine during the 2009 pandemic","volume":"15","author":"Ito","year":"2020","journal-title":"PLoS One"},{"issue":"16","key":"10.1016\/j.vaccine.2023.05.068_b0185","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/S0264-410X(03)00071-9","article-title":"The annual production cycle for influenza vaccine","volume":"21","author":"Gerdil","year":"2003","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2023.05.068_b0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009171","article-title":"Balancing the influenza neuraminidase and hemagglutinin responses by exchanging the vaccine virus backbone","volume":"17","author":"Gao","year":"2021","journal-title":"PLoS Pathog"},{"issue":"4","key":"10.1016\/j.vaccine.2023.05.068_b0195","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/infdis\/162.4.800","article-title":"Comparative long-term effects in a mouse model system of influenza whole virus and purified neuraminidase vaccines followed by sequential infections","volume":"162","author":"Johansson","year":"1990","journal-title":"J Infect Dis"},{"issue":"18","key":"10.1016\/j.vaccine.2023.05.068_b0200","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/0264-410X(95)00127-M","article-title":"Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans","volume":"13","author":"Kilbourne","year":"1995","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2023.05.068_b0205","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1128\/iai.29.3.966-971.1980","article-title":"Further studies of the neuraminidase content of inactivated influenza vaccines and the neuraminidase antibody responses after vaccination of immunologically primed and unprimed populations","volume":"29","author":"Kendal","year":"1980","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2023.05.068_b0210","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1128\/jvi.67.10.5721-5723.1993","article-title":"Dissociation of influenza virus hemagglutinin and neuraminidase eliminates their intravirionic antigenic competition","volume":"67","author":"Johansson","year":"1993","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2023.05.068_b0215","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.vaccine.2012.10.065","article-title":"Randomized comparative study of the serum antihemagglutinin and antineuraminidase antibody responses to six licensed trivalent influenza vaccines","volume":"31","author":"Couch","year":"2012","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2023.05.068_b0220","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1016\/j.vaccine.2009.12.041","article-title":"A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects","volume":"28","author":"Cate","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.05.068_b0225","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.786617","article-title":"Influenza neuraminidase characteristics and potential as a vaccine target","volume":"12","author":"Creytens","year":"2021","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2023.05.068_b0230","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41573-019-0056-x","article-title":"Next-generation influenza vaccines: Opportunities and challenges","volume":"19","author":"Wei","year":"2020","journal-title":"Nat Rev Drug Discov"},{"issue":"653","key":"10.1016\/j.vaccine.2023.05.068_b0235","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abo2167","article-title":"An inactivated multivalent influenza A virus vaccine is broadly protective in mice and ferrets","volume":"14","author":"Park","year":"2022","journal-title":"Sci Transl Med"},{"issue":"2","key":"10.1016\/j.vaccine.2023.05.068_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.102891","article-title":"Influenza virus and pneumococcal neuraminidases enhance catalysis by similar yet distinct sialic acid-binding strategies","volume":"299","author":"Klenow","year":"2023","journal-title":"J Biol Chem"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23006291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23006291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:29:07Z","timestamp":1759404547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23006291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":48,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0264410X23006291"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.05.068","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inactivated influenza virions are a flexible vaccine platform for eliciting protective antibody responses against neuraminidase","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.05.068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}